Ionis Pharmaceuticals

Phase 3 AI-extracted

pelacarsen

Lp(a)-CVD

Resolved

7days ago

Phase 3 readout · ~ Jun 30, 2026 estimated

What's at stake Phase 3 trial results for pelacarsen in Lp(a)-CVD are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 13h ago

“Results from Phase 3 Lp(a) HORIZON cardiovascular outcomes study of pelacarsen, an Ionis-discovered investigational medicine for lipoprotein(a) (Lp(a))-driven cardiovascular disease (CVD) (Novartis) o Results expected in H1 2026”

Add to calendar Post on X Reddit

Provenance